Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4 <sup>+</sup> T Cell Responses-Reference-Cited by-同舟云学术

Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4 ⁺ T Cell Responses

Published:2022-03-23 Issue:6 Volume:96 Page:
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:J Virol

Author:

Kim Eun-Ha¹,Nguyen Thi-Quyen¹²,Casel Mark Anthony B.¹,Rollon Rare¹,Kim Se-Mi³,Kim Young-Il³,Yu Kwang-Min¹,Jang Seung-Gyu¹³,Yang Jihyun⁴,Poo Haryoung⁴,Jung Jae U.⁵^ORCID,Choi Young Ki¹³^ORCID

Affiliation:

1. College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju, Republic of Korea

2. Vinmec Research Institute of Stem Cell and Gene Technology, Vinmec Healthcare System, Hanoi, Vietnam

3. Center for Study of Emerging and Re-emerging Viruses, Korea Virus Research Institute, Institute for Basic Science (IBS), Daejeon, Republic of Korea

4. Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology, University of Science and Technology, Daejeon, Republic of Korea

5. Department of Cancer Biology and Global Center for Pathogens Research and Human Health, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA

Abstract

The cocirculation of influenza virus merging with the COVID-19 pandemic raises a potentially severe threat to public health. Recently, increasing numbers of SARS-CoV-2 and influenza virus coinfection have been reported from many countries.

Funder

Institute for Basic Science

Korea Research Institute of Bioscience and Biotechnology

MOHW | Korea National Institute of Health

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/jvi.01873-21

Reference39 articles.

1. The Coronavirus Disease 2019 (COVID-19) Pandemic